Piperacillin and Restoril drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Piperacillin (piperacillin sodium) and Restoril (temazepam). Common drug interactions include chronic kidney disease among females and cellulitis among males.

The phase IV clinical study analyzes what interactions people have when they take Piperacillin and Restoril. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Piperacillin?

Piperacillin has active ingredients of piperacillin sodium. eHealthMe is studying from 5,597 Piperacillin users. Check the latest studies of Piperacillin.

What is Restoril?

Restoril has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 13,522 Restoril users. Check the latest studies of Restoril.



On Jul, 18, 2026

13 people who take Piperacillin and Restoril together, and have interactions are studied.

Piperacillin and Restoril drug interactions.

What are the common drug interactions of Piperacillin and Restoril, by gender? *:

female:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
  4. Renal tubular necrosis (death of kidney tubules)

male:

  1. Cellulitis (infection under the skin)
  2. Sepsis (a severe blood infection that can lead to organ failure and death)
  3. Rectal abscess (pus in rectum)
  4. Renal failure (kidney dysfunction)
  5. Dyspnoea (difficult or laboured respiration)
  6. Hypotension (abnormally low blood pressure)
  7. Renal failure acute (rapid kidney dysfunction)
  8. Scrotal abscess (pus in scrotum)
  9. Scrotal erythema (redness of scrotum area)
  10. Thrombocytopenia (decrease of platelets in blood)

What are the common drug interactions of Piperacillin and Restoril, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Abscess (pus)
  3. Anal abscess
  4. Cellulitis (infection under the skin)
  5. Chronic kidney disease
  6. Groin abscess (pus in groin)
  7. Leukocytosis (increased white blood cells)
  8. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
  9. Perineal abscess
  10. Perirectal abscess

60+:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  4. Cardiac disorder
  5. Cellulitis (infection under the skin)
  6. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  7. Erythema (redness of the skin)
  8. Lung infection
  9. Pyrexia (fever)
  10. Renal tubular necrosis (death of kidney tubules)

What are the existing conditions these people have? *

  1. Weight Decreased: 4 people, 30.77%
  2. Hypotension (abnormally low blood pressure): 4 people, 30.77%
  3. Type 2 Diabetes: 4 people, 30.77%
  4. Pain: 4 people, 30.77%
  5. Nausea (feeling of having an urge to vomit): 3 people, 23.08%
  6. Stress And Anxiety: 3 people, 23.08%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 15.38%
  8. Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 2 people, 15.38%
  9. Sinus Congestion (blockage of sinus): 2 people, 15.38%
  10. Neutropenic Colitis (inflammation of the cecum, often with involvement of the ascending colon and ileum, a life threatening condition): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Piperacillin and Restoril?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Piperacillin and Restoril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Piperacillin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Restoril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Piperacillin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Restoril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on piperacillin sodium and temazepam (the active ingredients of Piperacillin and Restoril, respectively), and Piperacillin and Restoril (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: